AMP-activated protein kinase and familial Wolff-Parkinson-White syndrome: New perspectives on heart development and arrhythmogenesis

European Heart Journal

Volumn 23, Issue 9, 2002, Pages 679-681

  Gollob, M H ^a   Robert, R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE;

ARRHYTHMOGENESIS; CHROMOSOME 7Q; CLINICAL FEATURE; DISEASE ASSOCIATION; EDITORIAL; ENZYME ACTIVITY; GENE LOCUS; GENETIC LINKAGE; HEART DEVELOPMENT; HEART HYPERTROPHY; HUMAN; PRIORITY JOURNAL; WOLFF PARKINSON WHITE SYNDROME;

FAMILY HEALTH; HEART; HUMANS; LINKAGE (GENETICS); MULTIENZYME COMPLEXES; MUTATION; PROTEIN-SERINE-THREONINE KINASES; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 0036558636     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2954     Document Type: Editorial

References (22)

1. Towbin JA, Vatta M, Li H. Genetics of brugada, long QT, and arrhythmogenic right ventricular dysplasia syndromes. J Electrocardiol 2000; 33 (Suppl): 11-22.
2. Priori SG, Napolitano C, Tiso N et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200.
3. Laitinen PJ, Brown KM, Piippo K et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485-90.
4. Gollob MH, Green MS, Tang A et al. A causative gene for familial Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 24 (Part II), 598. 4-1-2001. April 2001, presented at the 23rd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology, Boston, MA, 3 May, 2001.
5. Gollob MH, Green MS, Tang A et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001; 344: 1823-64.
6. Gollob MH, Seger JJ, Gollob TN et al. A novel PRKAG2 mutation in the genetic syndrome of ventricular preexcitation and conduction defects with childhood onset and absence of cardiac hypertrophy. Circulation. In press.
7. Mehdirad AA, Fatkin D, DiMarco JP et al. Electrophysiologic characteristics of accessory atrioventricular connections in an inherited form of Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 1999; 10: 629-35.
8. MacRae CA, Ghasia N, Kass S et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995; 96: 1216-20.
9. Salt I, Celler JW, Hawley SA et al. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha 2 isoform. Biochem J 1998; 334 (Pt 1): 177-87.
10. Hubert A, Husson A, Chedeville A, Lavoinne A. AMP-activated protein kinase counteracted the inhibitory effect of glucose on the phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes. FEBS Lett 2000; 481: 209-12.
11. Schott JJ, Benson DW, Basson CT et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998; 281 (5373): 108-11.
12. Benson DW. Advances in cardiovascular genetics and embryology: role of transcription factors in congenital heart disease. Curr Opin Pediatr 2000; 12: 497-500.
13. Hallows KR, Raghuram V, Kemp BE, Witters LA, Foskett JK. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 2000; 105: 1711-21.
14. Kiehn J. Regulation of the cardiac repolarizing HERG potassium channel by protein kinase A. Trends Cardiovasc Med 2000; 10: 205-9.
15. Abbud W, Habinowski S, Zhang JZ et al. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glutl-mediated glucose transport. Arch Biochem Biophys 2000; 380: 347-52.
16. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, Goodyear LJ. Metabolic stress and altered glucose transport: Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 2000; 49: 527-31.
17. Cheung PC, Salt IP, Davies DG, Hardie DG, Carling D. Characterization of AMP-activated protein kinase gammasubunit isoforms and their role in AMP binding. Biochem J 2000; 346: 659-69.
18. Kishi K, Yuasa T, Minami A et al. AMP-activated protein kinase is activated by the stimulation of G (q)-coupled receptors. Biochem Biophys Res Commun 2000; 276: 16-22.
19. Milan D, Jeon JT, Looft C et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 2000; 288: 1248-51.
20. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001; 104: 557-67.
21. Chen ZP, Mitchelhill KI, Michell BJ et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999; 443: 285-9.
22. Shesely EG, Maeda N, Kim HS et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93: 13176-81.